Orgenesis Competitors and Similar CompaniesClear all
Orgenesis's competitors and similar companies include Poltreg and BioGenCell.
 Orgenesis Orgenesis focuses on a novel therapeutic treatment for diabetes by correcting malfunctioning organs with new functional tissues. |  BioGenCell BioGenCell is a company developing a technology platform to creare treatment for blood vessel diseases typical of diabetes complication, smoking and arthrosclerosis. | ||
Founding Date | Founding Date 2008 | Founding Date 2015 | Founding Date 2008 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Germantown, US HQ Aye, BE Ness Ziona, IL Suwon Si, KR | Locations Gdańsk, PL HQ Gdańsk, PL | Locations HQ |
Employees | Employees 524% decrease | Employees 5 | Employees 15 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 55.5k (about 10 years ago) | Latest funding round $ 16m (about 4 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 55.5k | Total funding raised $ 16m |
For sources of this data, please see the company profile
View Company Profiles
Poltreg
HQ
Gdańsk, PL
Employees
5
Poltreg is a company that provides therapy for the treatment of type 1 diabetes.
View companyBioGenCell
HQ
Employees
15
BioGenCell is a company developing a technology platform to creare treatment for blood vessel diseases typical of diabetes complication, smoking and arthrosclerosis.
View company